Cellsearch
Device Diagnostics
General payments
$1,147,796
Research payments
$3,775,319
Through program year 2025, $1,147,796 in general payments and $3,775,319 in research payments were reported against Cellsearch (Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $254,849 | 669 |
| 2025 | Research | $1,493,083 | 307 |
| 2024 | General | $251,880 | 477 |
| 2024 | Research | $1,116,434 | 282 |
| 2023 | General | $203,970 | 300 |
| 2023 | Research | $736,102 | 88 |
| 2022 | General | $147,428 | 65 |
| 2022 | Research | $246,948 | 19 |
| 2021 | General | $94,510 | 1 |
| 2021 | Research | $182,753 | 10 |
| 2020 | General | $85,963 | 1 |
| 2019 | General | $109,196 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 44 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,514 general · 706 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.